Published on Canadian Women's Health Network (https://cwhn.ca)

Home > Printer-friendly

Diane-35 (cyproterone acetate): safety concerns

Tagged :
Print [6]
Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Paper
Online
Publisher: 
Canadian Medical Association Journal
Publication Date: 
2003
Publication Place: 
Ottawa, ON

Discusses warnings regarding the drug, Diane-35, and the drug's risk of venous thromboembolism. States that Diane-35 should be reserved for temporary use in women with serious acne and should not be used solely as an oral contraceptive.

Available From: 
Canadian Medical Association [7]
URLs: 
http://www.cmaj.ca/cgi/content/full/168/4/455 [8]
http://www.cmaj.ca/cgi/reprint/168/4/455.pdf [9]
Source URL: https://cwhn.ca/en/node/22708

Links:
[1] https://cwhn.ca/en/taxonomy/term/3871
[2] https://cwhn.ca/en/taxonomy/term/4285
[3] https://cwhn.ca/en/taxonomy/term/4259
[4] https://cwhn.ca/en/taxonomy/term/4151
[5] https://cwhn.ca/en/taxonomy/term/4147
[6] https://cwhn.ca/print/22708
[7] https://cwhn.ca/en/node/15282
[8] http://www.cmaj.ca/cgi/content/full/168/4/455
[9] http://www.cmaj.ca/cgi/reprint/168/4/455.pdf